Head and Neck Cancer Treatment Update: Pembrolizumab, Nivolumab and PD-L1 Markers

4 Views
administrator
administrator
07/06/23

Drs. Jared Weiss and Josh Bauml join GRACE to discuss updates relating to pembrolizumab, nivolumab and and PD-L1 markers for head and neck cancers.
http://cancerGRACE.org/

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next